1. Global Clinical Development, Translational and Precision Medicine, Chiesi, Parma, Italy;
2. Almac Diagnostics, Craigavon, United Kingdom; and
3. Medicines Evaluation Unit, The University of Manchester, Manchester University NHS Foundation Hospital Trust, Manchester, United Kingdom